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Abstract 
The synthesis of 4-substituted 2-(2-arylhydrazinyl)thiazol-3-ium bromides and 4-aryl-2-(substituted amino)-3-(phenylamino)- 
thiazol-3-ium bromide derivatives in high yields from the interaction of mono- and di-substituted thiosemicarbazides with 
phenacyl bromide derivatives is reported. The synthesized products have been elucidated using various spectroscopic tools 
such as IR, NMR, and mass spectrometry. Also the structure of three of the obtained compounds have been confirmed using 
X-ray crystallographic analyses, which showed that compounds 2-[2-(2,4-dinitrophenyl)hydrazinyl]-4-phenylthiazol-3-ium 
bromide and 4-phenyl-2,3-bis(phenylamino)thiazol-3-ium bromide crystals have a monoclinic shape and belonged to space 
group P21/c, whereas the crystals of 4-phenyl-2-(2-tosylhydrazinyl)thiazol-3-ium bromide show an orthorhombic shape 
with the space group Pbca
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Introduction
Generally the thiazole core occurs in variety of pharmaceu-
tical drugs [1]. For example, the water-soluble vitamin B1 
thiamine possesses a thiazole ring within its structure [2]. In 
addition, the thiazole ring system appears in the bacitracin 
and penicillin antibiotics and plays a great role in the con-
struction of synthetic drugs [1].
Synthetic drugs related to thiazole family recorded as 
antimicrobial agents acinitrazole and sulfathiazole [3], peni-
cillin which used as antibiotic [4, 5], pexole antidepressant 
drugs [6], bleomycin antineoplastic agents and tiazofurin 
[7], ritonavir used as anti-HIV drug [8], cinalukast antiasth-
matic drug [9], nizatidine antiulcer agent [10]. The non-ste-
roidal immunomodulatory drug fanetizole was extensively 
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used as thiazole derivatives [11] and meloxicam used as 
anti-inflammatory drug [12]. Thiazole derivatives possess 
polyoxygenated phenyl molecule that showed anti-fungal 
activity [13]. Thiazolium salts and bis-thiazolium salts have 
been prepared and examined as antimalarial potent agents 
[14]. Imidazo[2,1-b]thiazolium bromides showed analgesic 
and anti-inflammatory activities [15].
The synthetic strategies of thiazolium bromide heterocy-
clic cores were achieved via more than one step reaction, in 
which the thiazole ring was constructed first, then alkyla-
tion of the thiazole ring using alkyl bromide derivatives, 
for instance N-dodecylthiazolium bromide, and N-dodecyl-
4-methylthiazolium bromide, were observed during the reac-
tion of 1-bromododecane and thiazole/4-methylthiazole, and 
have been investigated as antimicrobial agents [16]. A few 
reactions have been reported for the synthesis of thiazo-
lium bromides in one step procedures, such as the reaction 
between thiosemicarbazide and 2-bromo-1-(4-chlorophenyl)-
ethanone affording 1-[5-(4-chlorophenyl)thiazol-2-yl]hydra-
zine hydrobromide and investigated as antibacterial [17]. 
Also, (E)-2-[2-(2-nitrobenzylidene)hydrazinyl]-4-phenylthi 
azol-3-ium bromide was synthesized from the reaction of 
1-aryl-2-bromoethanones with 2-(1-substituted methylidene)-
hydrazinecarbothioamides [18].
Polymethylene-bridged thiazolium and benzothiazolium 
salts (plus bases) were used as catalysts for the benzoin con-
densation; bis(thiazolin-2-ylidene) not thiazolin-2-ylidenes, 
were found to be the catalytic species in the benzoin con-
densation catalyzed by thiazolium salts plus base [19]. 
Thiazolium bromide salts have been used as catalyst for the 
synthesis of 1,4-diketones via hydroacylation of chalcones 
(α,β-unsaturated ketones) with aldehydes [20].
3-[2-(1-Butyl-1H-imidazol-1,3-ium-3-yl)ethyl]-4,5-di-
methyl-1,3-thiazol-3-ium was used as an ionic liquid in 
the conversion of aldehydes to acyloins and benzoins [21]. 
Thiazolium salts have been synthesized and their properties 
as ionic liquid catalyst have been studied; thiazolium halide 
ionic liquids were synthesized by using 4-methylthiazole or 
4-methyl-5-thiazolethanol and alkyl halides [22].
Reactions between mono-substituted thiosemicarbazides 
with phenacyl bromide derivatives in ethanol at refluxing 
temperature have been reported and gave 2-amino-5-(4-
aminophenyl)-4-(phenyl)-1,3-thiazol-3-ium bromide dihy-
drate derivatives. Also the same reactions have been car-
ried out using Eschenmoser coupling reaction conditions, 
triethyl amine (base) and triphenylphosphine (thiophile) in 
acetonitrile resulting in the formation of diazinylthiazole 
derivatives [23].
Lee et al. reported that the synthesis of 2-amino-5-(p-
aminophenyl)thiazoles and 5,5′-bis(2-aminothiazole) deriva-
tives via [5.5] sigmatropic shift of N-phenyl-N′-(2-thiazolyl)-
hydrazones and N,N′-bis(2-thiazolyl)hydrazines in acid 
catalyzed benzidine type rearrangement [24].
Results and discussion
Reaction between 4‑substituted thiosemicarbazides 
and phenacyl bromides
Herein, we investigate the reactions between 4-substituted 
thiosemicarbazides 1a–1d with phenacyl bromide deriva-
tives (as α-halocarbonyl compounds) 2a and 2b in ethyl 
acetate at room temperature that resulted in the formation of 
4-substituted-2-(2-substituted hydrazinyl)thiazol-3-ium bro-
mide 3a–3g in high yields (84–93%) as showed in Scheme 1. 
The structures of the synthesized compounds 3a–3g were 
identified using various tools of spectroscopic analyses, and 
also the structure of 3a and 3d were confirmed using X-ray 
analyses.
In the IR spectrum of compound 3a, broad bands were 
observed at 3220 cm−1 due to NH, 3102 cm−1 because of 
aromatic-CH, at 1611 cm−1 due to C=N, at 1591 cm−1 attrib-
uted to aromatic C=C, and at 1535 and 1331 cm−1 due to 
 NO2 group.
The 1H NMR spectra of 3a showed broad signals at 
δ = 10.20 ppm due to NH-attached directly to 2,4-dini-
trophenyl moiety, while NH-attached to C-2 appeared at 
10.63 ppm. The two NH-protons show downfield shift, 
attributed to the high deshielding caused by the di-nitro 
groups on the aromatic ring and the positive charge on thi-
azole-ring, respectively, as observed from the X-ray struc-
ture analysis of 3a. The thiazole-H occurred at 7.82 ppm as 
singlet signal. The aromatic protons appeared at 7.21–7.40 
and 7.48–7.55 ppm due to the phenyl protons. The pro-
tons appeared at 8.34–8.43 and 8.83–8.92 ppm are of the 
2,4-dinitrophenyl protons.
In 13C NMR of 3a, signals at 115.6, 150.5, and 170.5 ppm 
due to thiazole C-5, C-4, and C-2 respectively, also the 
downfield shift attributed to the positive charge on the thia-
zole ring. The aromatic carbons appeared at the aromatic 
region as mentioned in the experimental part.
The mass spectrum of 3a showed that m/z = 443  (M+) 
confirmed the formation of the thiazolium bromide prod-
ucts via the condensation between thiosemicarbazide 1a and 
phenacyl bromide 2a. The base peak at m/z = 358 resulted 
under liberation of HBr molecule.
X‑ray structure of compounds 3a and 3d
The structure of 3a–3g was further confirmed by X-ray dif-
fraction of 4-phenyl-2-[2-(2,4-dinitrophenyl)hydrazinyl]-
thiazol-3-ium bromide (3a; Fig. 1 and Tables 1–7 in the 
supplementary data: note that the crystal numbering does 
not obey the IUPAC numbering rules) and 4-phenyl-2-(2-
tosylhydrazinyl)thiazol-3-ium bromide (3d; Fig. 2 and 
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Tables 8–14 in the supplementary data), both showed the 
planarity of the thiazole ring.
Plausible mechanism for the formation 
of hydrazinylthiazolium bromide derivatives 3a–3g
The plausible mechanism for the formation of 3a–3g was 
demonstrated in Scheme 2 as follows: S-alkylation takes 
place via nucleophilic substitution and elimination of HBr 
molecule to give intermediate 4. Heterocyclization of 4 
through nucleophilic attack of  N4 on the carbonyl-group 
followed by elimination of  H2O molecule gives 6. In the 
presence of HBr the thiazolium bromide derivatives 3a–3g 
are formed.
Reactions between 1,4‑disubstituted 
thiosemicarbazides 7a–7e and phenacyl bromide 2a
Also, in this paper we investigate the reactions between 
1,4-disubstituted thiosemicarbazides 7a–7e and phenacyl 
bromide (2a) in ethyl acetate at room temperature result-
ing in the formation of 4-aryl-2-(amino)-3-(phenylamino)
thiazol-3-ium bromide derivatives 8a–8e in high yields 
(88–97%) instead of (Z)-3-substituted 4-diphenyl-2-(2-
phenylhydrazono)-2,3-dihydrothiazoles 9a–9e [23] 
(Scheme 3). Here, we try to carry out the reaction in a 
variety of solvents and conditions; we found that the prod-
ucts were formed in high yields and purity when the reac-
tions were carried out in ethyl acetate at room temperature 
(Table 1).
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Fig. 1  Molecular X-ray structure of 2-[2-(2,4-dinitrophenyl)hydrazinyl]-4-phenylthiazol-3-ium bromide (3a)
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The structures of compounds 8a–8e were confirmed using 
spectroscopic methods, such as IR, 1H NMR, 13C NMR, 
and mass spectrometry as well as X-ray crystallographic 
analysis.
In IR spectrum of 8a there are characteristic absorption 
bands that appeared at 3220–3175 cm−1 assigned to NH-
group vibrations, aromatic-CH vibrations observed in the 
Fig. 2  Molecular X-ray structure of 4-phenyl-2-(2-tosylhydrazinyl)thiazol-3-ium bromide (3d)
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region around 3025–3135 cm−1, and absorption band at 
1595 cm−1 assigned to Ar–C=C vibrations..
From the 1H NMR spectra of 8a it was cleared that broad 
singlet signals appeared downfield at δ = 9.88 ppm due to 
deshielded NH-proton, the downfield shift caused by the 
occurrence of the positive charge on the thiazole-ring, and 
the other NH-proton appeared within the aromatic protons.
The 13C NMR showed signals at δ = 112.7, 138.0, and 
168.6 ppm for thiazole C-5, C-4, and C-2, respectively. The 
aromatic carbons appeared at the characteristic region as 
illustrated in the experimental part.
The interaction between 7a–7e and 2a resulted in the 
formation of 4-aryl-2-(substituted amino)-3-(phenylamino)-
thiazol-3-ium bromide derivatives 8a–8e was supported 
from the mass spectrometry of compound 8a which showed 
m/z = 425  (M+) this peak is due to the presence of HBr mol-
ecule and formation of the thiazolium salt and base peak 
m/z = 343 support the loss of HBr molecule.
X‑ray structure of compound 8a
Also, the structures were unambiguously confirmed 
from X-ray obtained for the compound 4-phenyl-
2,3-bis(phenylamino)thiazol-3-ium bromide (8a; Fig. 3 and 
Tables 15–21; note that the crystallographic numbering 
does not correspond to the systematic IUPAC numbering 
rules). The thiazole ring is planar (mean deviation from the 
L.S.-plane S1, C2, N3 C4, C5 0.0036 Å), while the phe-
nyl substituent and the two NHPh moieties are twisted or 
orthogonal in respect to the thiazole ring (angle between the 
L.S. planes 42.44(6)° for C41…C46, 57.92(6)° for N21 and 
84.00(5)° for N31).
Plausible mechanism for the formation 
of 2,3,4‑trisubstituted thiazolium bromides 8a–8e
According to the above results, proposed mechanism for the 
formation of 4-aryl-2-amino-3-(phenylamino)thiazol-3-ium 
bromide derivatives 8a–8e is illustrated in Scheme 4. This 
showed that the heterocyclization takes place via sulfur atom 
and  N2 due to their high nucleophilicity (Scheme 4).
Optimization of the reaction conditions 
between thiosemicarbazides and phenacyl 
bromides
Therefore, the optimized reaction conditions involved mix-
ing equimolar amounts of compound 1a–1d or 7a–7e and 
2a, 2b at room temperature in ethyl acetate (as dipolar 
aprotic solvent). The solvent, temperature, and the molar 
ratio of the reactants may all play a critical role on the reac-
tion pathway and these variables were investigated. Different 
solvents such as tetrahydrofuran (THF), 1,2-dichloroethane, 
and acetonitrile were studied, but ethyl acetate proved to be 
the selective solvent. The main factor that controls the pro-
cess to obtain the target products is to carry out the reactions 
at room temperature and ethyl acetate was the best solvent 
chosen to get high yields.
Increasing the amounts of compound 1a–1d or 7a–7e 
showed that there were no needs to improve the yields of 
products. The effect of different basic media was investi-
gated, and ethyl acetate without any additive showed high 
activity.
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Conclusion
Our studies resulted in the construction of novel two 
groups of substituted thiazolium salts 2,4-disubstituted and 
2,3,4-trisubstituted thiazolium bromide derivatives in high 
yields via one step reaction and at ambient temperature in 
the presence of ethyl acetate as solvent. Simple and efficient 
procedures were used to synthesize the thiazolium bromides.
Fig. 3  Molecular X-ray structure of 4-phenyl-2,3-bis(phenylamino)thiazol-3-ium bromide (8a)
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Experimental
Gallenkamp melting point apparatus was used to determine 
the melting points. IR spectra were recorded with Alpha, 
Bruker FT-IR instruments using potassium bromide pellets. 
NMR spectra were recorded for 1H NMR at 400 MHz and 
13C NMR at 100 MHz on a Bruker AM 400 spectrometrer 
with TMS as internal standard (δ = 0 ppm), and data are 
reported as follows: chemical shift, multiplicity (s = singlet, 
t = triplet, q = quartet, m = multiplet, and br = broad). For 13C- 
NMR, spectra were obtained with complete proton decou-
pling. Finnigan MAT instrument was used to record the mass 
spectra (70 eV, EI-mode). Elemental analyses for C, H, N, 
and S were carried out using an Elmer 306.
Mono and di-substituted thiosemicarbazides were pre-
pared according to literature methods (1a [24], 1b [25], 1c 
[26], 1d [27], 7a–7e [28]). Phenacyl bromides 2a, 2b were 
prepared according to literature [29, 30].
Synthesis of 4‑substituted 2‑(2‑hydrazinyl)
thiazol‑3‑ium bromides 3a–3g
A solution of 1.0 mmol of N-substituted thiosemicarbazides 
1a–1d in 15  cm3 ethyl acetate was added to 1.0 mmol of 
phenacyl bromides 2a, 2b dissolved in 10  cm3 ethyl acetate. 
The mixture was stirred for 30 min and allowed to stand 
overnight, after completion of the reaction; the formed pre-
cipitate was filtered, washed several times with ethyl acetate 
to afford the target products 3a–3g (yields 84–93%).
2‑[2‑(2,4‑Dinitrophenyl)hydrazinyl]‑4‑phenylthiazol‑3‑ium 
bromide  (C15H12BrN5O4S, 3a) Orange crystals (acetonitrile); 
yield 0.394 g (90%); m.p.: 202–204 °C; 1H NMR (400 MHz, 
DMSO-d6): δ = 7.21–7.40 (m, 5H, Ar–H), 7.48–7.55 (m, 1H, 
Ar–H), 7.82 (s, 1H, thiazole-H), 8.34–8.43 (m, 1H, Ar–H), 
8.83–8.92 (m, 1H, Ar–H), 10.20 (br, s, 1H, NH), 10.63 (br, 
s, 1H, NH) ppm; 13C NMR (100 MHz, DMSO-d6): δ = 115.6 
(C-5), 123.9, 125.5, 127.6, 128.6, 130.0, 130.4 (Ar–CH), 
131.3, 134.8, 136.4, 148.6 (Ar–C), 150.5 (C-4), 170.5 (C-2) 
ppm; IR (KBr): v = 3220 (NH), 3102 (Ar–CH), 1611 (C=N), 
1591 (Ar–C=C), 1528 and 1335  (NO2)  cm−1; MS (70 eV): 
m/z = 439/441  (M+, 6), 357  (M+-HBr, 28), 257 (10), 191 
(15), 168 (46), 153 (100), 105 (18), 91 (25).
4‑Phenyl‑2‑(2‑phenylhydrazinyl)thiazol‑3‑ium bromide 
 (C15H12BrN5O4S, 3b) Colorless crystals (acetonitrile); yield 
0.309 g (89%); m.p.: 152–153 °C; 1H NMR (400 MHz, 
DMSO-d6): δ = 7.36–7.48 (m, 4H, Ar–H), 7.61–7.70 (m, 
3H, Ar–H and thiazole-H), 7.97–8.08 (m, 5H, Ar–H and 
NH), 8.39 (br, s, NH) ppm; 13C NMR (100 MHz, DMSO-
d6): δ = 117.6 (C-5), 123.5, 125.9, 128.6, 129.0, 129.9, 133.4 
(Ar–CH), 133.5, 155.1 (Ar–C), 150.9 (C-4), 175.4 (C-2) 
ppm; IR (KBr): v = 3175 (NH), 3097 (Ar–CH), 1618 (C=N), 
1577 (Ar–C=C)  cm−1; MS (70 eV): m/z = 347/349  (M+, 9), 
267  (M+-HBr, 100), 191 (33), 167 (22), 105 (55), 77 (13).
2‑[2‑(3‑Chlorophenyl)hydrazinyl]‑4‑phenylthiazol‑3‑ium bro‑
mide  (C15H13BrClN3S, 3c) Colorless crystals (acetonitrile); 
yield 0.329 g (86%); m.p.: 163–164 °C; 1H NMR (400 MHz, 
DMSO-d6): δ = 6.98–7.22 (m, 3H, Ar–H and thiazole-H), 
7.39–7.52 (m, 2H, Ar–H and NH), 7.64–7.71 (m, 2H, Ar–H), 
7.91–8.07 (m, 4H, Ar–H), 8.45 (br, s, 1H, NH) ppm; 13C NMR 
(100 MHz, DMSO-d6): δ = 117.9 (C-5), 122.3, 123.3, 125.5, 
128.8, 129.2, 131.5, 132.2 (Ar–CH), 133.6, 134.8, 155.4 
(Ar–C), 151.7 (C-4), 175.1 (C-2) ppm; IR (KBr): v = 3215 
(NH), 3087 (Ar–CH), 1621 (C=N), 1589 (Ar–C=C)  cm−1; MS 
(70 eV): m/z = 383/387  (M+, 5), 303 (33), 301  (M+-HBr, 100), 
191 (22), 161 (23), 141 (29), 113 (47), 111 (15).
4‑Phenyl‑2‑(2‑tosylhydrazinyl)thiazol‑3‑ium bromide 
 (C16H16BrN3O2S2, 3d) Red crystals (acetonitrile); yield 
0.396 g (93%); m.p.: 185–186 °C; 1H NMR (400 MHz, 
DMSO-d6): δ = 2.35 (s, 3H,  CH3), 7.35–7.41 (m, 3H, Ar–H), 
7.50–7.62 (m, 5H, Ar–H and thiazole-H), 7.66–7.73 (m, 
2H, Ar–H), 10.02 (br, s, 1H, NH), 10.33 (br, s, 1H, NH) 
ppm; 13C NMR (100 MHz, DMSO-d6): δ = 20.9  (CH3), 
114.6 (C-5), 127.5, 128.7, 129.8, 130.0, 130.9 (Ar–CH), 
133.3, 134.9, 144.8 (Ar–C), 151.8 (C-4), 174.3 (C-2) ppm; 
IR (KBr): v = 3156 (NH), 3086 (Ar–CH), 2982 and 2832 
(ali-CH), 1597 (Ar–C=C)  cm−1; MS (70 eV): m/z = 425/427 
 (M+, 8), 345  (M+-HBr, 100), 191 (24), 185 (33), 161 (43), 
155 (65), 105 (8), 91 (6).
4‑(4‑Bromophenyl)‑2‑(2‑phenylhydrazinyl)thiazol‑3‑ium 
bromide  (C15H13Br2N3S, 3e) Colorless crystals (acetonitrile); 
yield 0.371 g (87%); m.p.: 176–177 °C; 1H NMR (400 MHz, 
DMSO-d6): δ = 7.48–7.52 (m, 3H, Ar–H and NH), 7.62–7.70 
(m, 3H, Ar–H and NH), 8.00–8.18 (m, 5H, Ar–H), 8.48 (br, 
s, NH) ppm; 13C NMR (100 MHz, DMSO-d6): δ = 114.6 
(C-5), 118.3, 122.9, 129.6, 130.7, 132.7 (Ar–CH), 123.5, 
127.9, 149.9 (Ar–C), 150.9 (C-4), 175.5 (C-2) ppm; IR 
(KBr): v = 3241 (NH), 3054 (Ar–CH), 2925 (ali-CH), 1623 
(C=N), 1597 (Ar–C=C)  cm−1; MS (70 eV): m/z = 427/431 
 (M+, 3), 347/349  (M+-HBr, 100), 271/273 (33), 241/243 
(46), 181/183 (25), 167 (7), 107 (20), 77 (55).
Table 1  Optimization of reaction conditions for the formation of 3a 
and 8a 
Entry Solvent Yield of 3a/% Yield of 8a/%
1 Tetrahydrofuran 34 29
2 1,2-Dichloroethane 46 36
3 Acetonitrile 39 32
4 Ethyl acetate 90 93
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4‑(4‑Bromophenyl)‑2‑[2‑(3‑chlorophenyl)hydrazinyl]thia‑
zol‑3‑ium bromide  (C15H12Br2ClN3S, 3f) Colorless crystals 
(acetonitrile); yield 0.387 g (84%); m.p.: 190–191 °C; 1H 
NMR (400 MHz, DMSO-d6): δ = 6.93–7.10 (m, 4H, Ar–H 
and thiazol-H), 7.37–7.51 (m, 2H, Ar–H and NH), 7.65–
7.73 (m, 1H, Ar–H), 7.94–8.05 (m, 3H, Ar–H), 8.45 (br, s, 
1H, NH) ppm; 13C NMR (100 MHz, DMSO-d6): δ = 119.1 
(C-5), 122.2, 124.3, 128.9, 129.6, 130.8, 132.4 (Ar–CH), 
123.0, 128.0, 134.5, 149.7 (Ar–C), 151.8 (C-4), 175.6 (C-2) 
ppm; IR (KBr): v = 3210 (NH), 3099 (Ar–CH), 1617 (C=N), 
1591 (Ar–C=C)  cm−1; MS (70 eV): m/z = 461/467  (M+, 6), 
381/385  (M+-HBr, 100), 269/271 (52), 201 (13), 181/183 
(41), 111/112 (71), 105 (83).
4‑(4‑Bromophenyl)‑2‑(2‑tosylhydrazinyl)thiazol‑3‑ium bro‑
mide  (C16H15Br2N3O2S2, 3g) Violet crystals (acetonitrile); 
yield 0.439 g (87%); m.p.: 213–215 °C; 1H NMR (400 MHz, 
DMSO-d6): δ = 2.38 (s, 3H,  CH3), 7.38–7.43 (m, 2H, Ar–H), 
7.48–7.57 (m, 5H, Ar–H and thiazole-H), 7.69–7.74 (m, 2H, 
Ar–H), 10.04 (br, s, 1H, NH), 10.31 (br, s, 1H, NH) ppm; 13C 
NMR (100 MHz, DMSO-d6): δ = 20.9  (CH3), 112.4 (C-5), 
127.8, 129.6, 130.2, 130.5 (Ar–CH), 121.9, 133.3, 135.0, 
144.8 (Ar–C), 151.8 (C-4), 173.9 (C-2) ppm; IR (KBr): 
v = 3225 (NH), 3094 (Ar–CH), 1615 (C=N), 1590 (Ar–C=C) 
and 1523 and 1333  (NO2)  cm−1; MS (70 eV): m/z = 505/509 
 (M+, 12), 425/427  (M+-HBr, 100), 269/271 (15), 241/243 
(12), 183 (35), 181 (15), 155 (55), 91 (90), 77 (50).
Synthesis of 4‑aryl‑2‑amino‑3‑(phenylamino)-
thiazol‑3‑ium bromide derivatives 8a–8e
To a stirred solution of 0.198  g phenacyl bromide 2a 
(1.0 mmol) in 10  cm3 ethyl acetate a solution of appro-
priate 1-phenyl-4-substituted thiosemicarbazides 7a–7e 
(1.0 mmol) in 15  cm3 ethyl acetate was added portion wise 
and the mixture allowed to stirred at room temperature. Dur-
ing the stirring a precipitate was formed after a few minutes. 
The reaction mixture was left overnight, and the precipitate 
was collected through filtration, washed with ethyl acetate 
several times to obtain the final products 8a–8e in high 
purity and in good yields (88–97%).
4‑Phenyl‑2,3‑bis(phenylamino)thiazol‑3‑ium bromide 
 (C21H18BrN3S, 8a) Colorless crystals (acetonitrile); yield 
0.394 mg (93%); m.p.: 165–167 °C; 1H NMR (400 MHz, 
DMSO-d6): δ = 6.60–6.68 (m, 2H, Ar–H), 6.78–6.82 (m, 
1H, Ar–H), 7.10–7.15 (m, 2H, Ar–H and thiazole-H), 7.28–
7.70 (m, 12H, Ar–H and NH), 9.88 (br, s, 1H, NH) ppm; 
13C NMR (100 MHz, DMSO-d6): δ = 112.7 (C-5), 121.5, 
123.6, 128.2, 128.5, 128.8, 129.0, 129.2, 129.9, 130.2 (Ar–
CH), 138.0 (C-4), 127.3, 141.1, 144.0 (Ar–C), 168.6 (C-2) 
ppm; IR (KBr): v = 3276 (NH), 3020–3110 (Ar–CH), 1595 
(Ar–C=C)  cm−1; MS (70 eV): m/z = 425/427  (M+, 4), 343 
 (M+-HBr, 100), 253 (40), 209 (3), 135 (18), 93 (5), 77 (57).
2‑(Allylamino)‑4‑phenyl‑3‑(phenylamino)thiazol‑3‑ium 
bromide  (C18H18BrN3S, 8b) Colorless crystals (acetoni-
trile); yield 0.376 g (97%); m.p.: 182–183 °C; 1H NMR 
(400 MHz, DMSO-d6): δ = 5.08–5.12 (m, 4H, allyl-CH2N), 
5.15–5.22 (allyl-CH2 =), 5.72–5.82 (m, 1H, allyl-CH =), 
6.80–6.86 (m, 2H, Ar–H and thiazole-H), 6.92–6.98 (m, 3H, 
Ar–H), 7.12–7.15 (m, 3H, Ar–H), 7.42–7.52 (m, 4H, Ar–H 
and NH), 9.42 (br, s, 1H, NH) ppm; 13C NMR (100 MHz, 
DMSO-d6): δ = 64.6 (allyl-CH2N), 113.6 (C-5), 118.8 (allyl-
CH2 =), 122.5, 127.2, 129., 129.4, 129.8, 130.7 (Ar–CH), 
134.7 (allyl-CH =), 139.6 (C-4), 142.3, 145.0 (Ar–C), 172.9 
(C-2) ppm; IR (KBr): v = 3280 (NH), 3025–3115 (Ar–CH), 
2990 and 2946 (ali-CH), 1598 (Ar–C=C)  cm−1; MS (70 eV): 
m/z = 387/389  (M+, 9), 307  (M+-HBr, 100), 253 (38), 209 
(36), 99 (51), 93 (58).
2‑(Ethylamino)‑4‑phenyl‑3‑(phenylamino)thiazol‑3‑ium 
bromide  (C17H18BrN3S, 8c) Colorless crystals (acetonitrile); 
yield 0.353 g (94%); m.p.: 157–158 °C; 1H NMR (400 MHz, 
DMSO-d6): δ = 1.12–1.18 (t, 3H, J = 6.77 Hz,  CH3), 3.96–
4.08 (q, 2H, J = 6.77 Hz,  CH2), 6.90–7.00 (m, 3H, Ar–H and 
thiazole-H), 7.12 (br, s, 1H, NH), 7.25–7.33 (m, 3H, Ar–H), 
7.50–7.68 (m, 5H, Ar–H), 9.32 (br, s, 1H, NH) ppm; 13C 
NMR (100 MHz, DMSO-d6): δ = 13.0  (CH3), 42.7  (CH2), 
113.4 (C-5), 121.4, 126.5, 127.4, 129.2, 129.8, 130.4 (Ar–
CH), 139.6 (C-4), 142.0, 145.9 (Ar–C), 172.8 (C-2) ppm; IR 
(KBr): v = 3265 (NH), 3023–3112 (Ar–CH), 2989 and 2940 
(ali-CH), 1597 (Ar–C=C)  cm−1; MS (70 eV): m/z = 375/377 
 (M+, 11), 295 (100), 253 (45), 209 (88), 195 (52), 102 (25), 
93 (41), 87 (29).
2‑(Cyclohexylamino)‑4‑phenyl‑3‑(phenylamino)thia‑
zol‑3‑ium bromide  (C21H24BrN3S, 8d) Colorless crystals (ace-
tonitrile); yield 0.387 g (90%); m.p.: 173–174 °C; 1H NMR 
(400 MHz, DMSO-d6): δ = 1.07–2.10 (m, 10H, cyclohexyl-
CH2), 3.75–3.93 (m, 1H, cyclohexyl-CH), 6.60–6.75 (m, 
3H, Ar–H and thiazole-H), 6.90–7.06 (m, 3H, Ar–H), 7.32–
7.58 (m, 3H, Ar–H), 7.80–7.91 (m, 2H, Ar–H), 8.36 (br, s, 
1H, NH), 9.80 (br, s, 1H, NH) ppm; 13C NMR (100 MHz, 
DMSO-d6): δ = 23.8, 31.8, 41.3 (cyclohexyl-CH2), 58.6 
(cyclohexyl-CH), 116.0 (C-5), 122.5, 126.4, 127.7, 128.8, 
129.4, 130.7 (Ar–CH), 137.9 (C-4), 143.8, 144.3 (Ar–C), 
173.9 (C-2) ppm; IR (KBr): v = 3269 (NH), 3018–3115 (Ar–
CH), 2996 and 2943 (ali-CH), 1591 (Ar–C=C)  cm−1; MS 
(70 eV): m/z = 429/431  (M+, 5), 349  (M+-HBr, 100), 253 
(52), 247 (36), 209 (21), 141 (33), 102 (31), 93 (36), 91 (62).
2‑(Benzylamino)‑4‑phenyl‑3‑(phenylamino)thiazol‑3‑ium 
bromide  (C22H20BrN3S, 8e) Colorless crystals (acetoni-
trile); yield 0.386 mg (88%); m.p.: 194–195 °C; 1H NMR 
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(400 MHz, DMSO-d6): δ = 5.40 (s, 2H,  CH2-benzyl), 6.72–
6.78 (m, 2H, Ar–H), 6.88–6.92 (m, 1H, Ar–H), 7.02–7.06 
(m, 2H, Ar–H), 7.20–7.28 (m, 3H, Ar–H, and thiazole-H), 
7.35–7.43 (m, 3H, Ar–H), 7.46–7.60 (m, 6H, Ar–H and NH), 
9.20 (br, s, 1H, NH) ppm; 13C NMR (100 MHz, DMSO-d6): 
δ = 49.9  (CH2-benzyl), 113.4 (C-5), 121.4, 126.2, 128.3, 
128.9, 129.0, 129.2, 129.5, 130.3 (Ar–CH), 138.5 (C-4), 
173.3 (C-2) ppm; IR (KBr): v = 3270 (NH), 3028–3109 (Ar–
CH), 2988 and 2938 (ali-CH), 1598 (Ar–C=C)  cm−1; MS 
(70 eV): m/z = 437/439  (M+, 10), 357  (M+-HBr, 100), 253 
(47), 209 (11), 149 (21), 93 (5), 91 (87), 77 (51).
Single crystal X‑ray structure determination 
of 3a, 3d, and 8a
The single-crystal X-ray diffraction study was carried out on 
a Bruker D8 Venture diffractometer with Photon II detector 
at 123(2) K using Cu–Kα radiation (λ = 1.54178 Å). Dual 
space methods (SHELXT) [31] were used for structure solu-
tion and refinement was carried out using SHELXL-2014 
(full-matrix least-squares on F2) [32]. Hydrogen atoms were 
refined using a riding model (H(N) free). Semi-empirical 
absorption corrections were applied.
Compound 3a:  C15H12N5O4S·Br, M = 438.27  g  mol−1, 
orange crystals, size 0.18 × 0.14 × 0.04 mm, monoclinic, 
space group P21/c (no.14), a = 15.2596(8) Å, b = 15.8466(8) 
Å, c = 7.1347(4) Å, β = 94.047(2)°, V = 1720.96(16) Å3, 
Z = 4, Dcalcd = 1.692 Mg m−3, F(000) = 880, µ = 4.70 mm−1, 
T = 123 K, 18,164 measured reflections (2θmax = 144.2°), 
3383 independent [Rint = 0.027], 244 parameters, 3 restraints, 
R1 [for 3226 I > 2σ (I)] = 0.024, wR2 (for all data) = 0.065, 
S = 1.05, largest diff. peak and hole = 0.45 e Å−3/ -0.21 e 
Å−3.
Compound 3d:  C16H16N3O2S2·Br, M = 426.35  g  mol−1, 
red crystals, size 0.12 × 0.06 × 0.04  mm, orthorhom-
bic, space group Pbca (no.62), a = 12.5822(5) Å, 
b = 15.4936(6) Å, c = 18.1813(8) Å, V = 3544.3(3) Å3, 
Z = 8, Dcalcd = 1.598 Mg m−3, F(000) = 1728, µ = 5.49 mm−1, 
T = 123 K, 36,334 measured reflections (2θmax = 144.4°), 
3499 independent [Rint = 0.032], 227 parameters, 3 restraints, 
R1 [for 3340 I > 2σ (I)] = 0.024, wR2 (for all data) = 0.064, 
S = 1.04, largest diff. peak and hole = 0.60 e Å−3/− 0.40 e 
Å−3.
Compound 8a:  C21H18N3S·Br, M = 424.35 g mol−1, colour-
less crystals, size 0.36 × 0.24 × 0.16 mm, monoclinic, space 
group P21/c (no.14), a = 10.7239(4) Å, b = 10.5069(4) Å, 
c = 16.6705(7) Å, β = 90.611(1)°, V = 1878.24(13) Å3, 
Z = 4, Dcalcd = 1.501 Mg m−3, F(000) = 864, µ = 4.09 mm−1, 
T = 123 K, 10,503 measured reflections (2θmax = 144.4°), 
3660 independent [Rint = 0.026], 241 parameters, R1 [for 
3633 I > 2σ (I)] = 0.024, wR2 (for all data) = 0.066, S = 1.10, 
largest diff. peak and hole = 0.50 e Å−3/− 0.27 e Å−3.
CCDC 1,963,830 (3a), 1,963,831 (3d), and 1,963,832 
(8a) contain the supplementary crystallographic data for 
this paper. These data can be obtained free of charge from 
The Cambridge Crystallographic Data Centre via www.ccdc.
cam.ac.uk/data_reque st/cif.
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